Startup Jobs
Search
Inositec logo

Inositec

Office

Headquarters

Technopark, Technoparkstrasse 1, 8005 Zürich, Switzerland

Office

Industry

HealthTech

Office

Website

About us

Inositec is pioneering the development of life-saving small molecule drugs based on inositol phosphate, a natural facilitator of diverse cellular functions. Using its broadly applicable technology to adjust the chemical and physical properties of inositol phosphate (IP6) analogs, Inositec is developing a novel class of drugs currently focusing on high-unmet medical needs related to calcification disorders. The lead compound INS-3001 is a cardiovascular calcification inhibitor in development for aortic valve stenosis. Inositec was founded in December 2015 based on the award-winning research of Dr. Mattias Ivarsson, Prof. Jean-Christophe Leroux and Prof. Bastien Castagner at ETH Zurich, Switzerland.

Organization size

Organization size

1-10 employees

Wanted occupations

Wanted occupations

Wanted field of studies

Wanted field of studies

Funding stage

Funding stage

Seed

Loading interface...
Loading interface...
Loading interface...
Loading interface...